Biotica discovers and develops novel polyketide therapeutics to create new medicines for serious diseases.
Biotica’s R&D pipeline is focused on optimised polyketide therapeutics for high-value indications. Biotica's compounds, generated using the proprietary novoPT™ technology, have unique chemistry and differentiated properties.
Polyketides are the basis of more than 40 successful therapeutics in a wide range of diseases. They make excellent leads for drug discovery, with naturally high affinity to biologically relevant targets, including protein-protein interactions and other traditionally difficult targets.
Biotica has formed successful partnerships with leading pharmaceutical companies, most recently Wyeth and GSK, based on its high-value projects. Projects are selected on three key criteria: market potential, clinical validation of the target and Biotica exclusivity.
Company Details
- Employees
- 48
- Founded
- 1996
- Address
- 3 Riverside, Suite 5, Granta Park,united Kingdom
- Phone
- +34 964 10 81 31
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- biotica.com
- Keywords
- Polyketides, drug discovery, pharmaceuticals.
- HQ
- Cambridge
Biotica Questions
Biotica's helpline number is +34 964 10 81 31
Biotica's website is biotica.com
Biotica's LinkedIn profile is https://uk.linkedin.com/company/biotica
Biotica has
48 employees.
View email and phone details for 48
employees at Biotica.
Biotica's industry is
Biotechnology Research
Biotica's categories are Biotechnology Research
Biotica's founding year is 1996
